| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |